Astria Therapeutics Current Deferred Revenue (Quarterly) Trends

Astria Therapeutics, Inc. (ATXS)

12.99 +0.04 (+0.31%) USD | NASDAQ | Dec 29, 16:00

13.50 +0.51 (+3.93%) After-Hours: 05:20

View Current Deferred Revenue (Quarterly) for ATXS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

BioCryst Pharmaceuticals, Inc.	--
Hologic, Inc.	Upgrade
Johnson & Johnson	--
Alnylam Pharmaceuticals, Inc.	Upgrade
CorMedix, Inc.	--